Clinical Research Directory
Browse clinical research sites, groups, and studies.
EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")
Sponsor: Akili Interactive Labs, Inc.
Summary
The EndeavorRx Prospective Product Registry aims to collect real world data from participants receiving the digital therapeutic, EndeavorRx, under conditions of routine clinical practice.
Official title: EndeavorRx® Prospective Product Registry
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2022-06-01
Completion Date
2025-12-31
Last Updated
2024-06-27
Healthy Volunteers
Not specified
Conditions
Interventions
EndeavorRx
EndeavorRx® is an FDA cleared digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type attention-deficit/hyperactivity disorder (ADHD), who have a demonstrated attention issue. EndeavorRx is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.
Locations (1)
Akili Interactive Labs, Inc.
Boston, Massachusetts, United States